ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1122

Factors Impacting Referral of Juvenile Idiopathic Arthritis Patients to a Tertiary Level Pediatric Rheumatology Center in North India

Caroline Freychet 1, Manjari Agarwal 2, Sumidha Mittal 2, Abhay Shivpuri 2, Anju Singh 2, Veronique Dinand 3 and Sujata Sawhney2, 1Department of pediatric rheumatology, Sir Ganga Ram Hospital, New Delhi, India, New Delhi, Delhi, India, 2Department of pediatric rheumatology, Sir Ganga Ram Hospital, New Delhi, India, New Delhi, India, 3Department of research, Sir Ganga Ram Hospital, New Delhi, India, New Dehli, India

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: juvenile idiopathic arthritis (JIA) and access to care

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Health Services Research Poster II – ACR/ARP

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: JIA studies demonstrate that there is a “window of opportunity” early in the disease course during which appropriate management improves outcomes: prompt referral to pediatric rheumatology (PR) center is crucial for best results. There are no publications about patient’s pathway until first PR visit from India. In this country, the number of JIA is huge: the estimated prevalence ranges from 350 000 to 1.3 million. Health-care costs are paid out of pocket by patients and there is a significant shortage of pediatric rheumatologists (PRsts) with approximately 15 PRst concentrated in urban centres. These parameters are likely to impact referral pathways. This study aimed to describe time from onset of symptoms to first PR visit of JIA patients to a tertiary center in India and to analyze predictive factors for time to referral.

Methods: This retrospective study is from data collected on JIA patients in the PR center, Institute of Child health, Sir Ganga Ram Hospital (SGRH) in New Delhi where both paid (private) and free (poor) patients are seen. JIA patients fulfilling ILAR 2004 criteria and seen at least twice from 01/10/2013 to 30/09/2018 were included. Data collected were: demographic details, history of the disease, referral practitioner, clinical and laboratory features, treatment. Patients previously assessed by PRst or with missing data were excluded. Mann-Whitney U-test, Chi square and logistic regression (univariate and multivariate) were used as appropriate to study factors that determined time to first PR visit.

Results: In all 520 patients were included (45% girls, median age 10 years, 71% were systemic JIA patients and enthesitis related arthritis patients (table 1)): 396 children were diagnosed at our PR center (group A), 124 were previously diagnosed as JIA and managed by non PRst before first PR visit (group B). Median time of symptom onset to first assessment in PR was 4.1 months and median distance travelled 119.5 km. Despite ongoing treatment at first PR visit, group B patients had more aggressive disease (active joint count 4 versus 3, p< 0.01; cervical involvement 10.5% versus 5.3 %, p< 0.05; children non attending to school 16.1% versus 9.1%, p< 0.05) and resided further away (205 km versus 79.6 km, p< 0.001). For group B patients, predominant referral doctor was adult rheumatologist (66%), for group A- pediatrician (50%) (table 2). On univariate analysis, factors that predicted PRst visit within 3 months were private patients, short distance to travel, family history of inflammatory disease, history of fever, history of acute uveitis or high ESR. On multivariate analysis all factors remained except high ESR.

Conclusion: Time to first PR assessment at this center is comparable to western countries(1). Cost of care and long distance to travel were factors that delayed consultation ; acuity of complaints, short distance to travel, adequate financial resources and a family member with rheumatologic condition hastened referral.

Possible factors to improve referral to PR centres would be to increase the number of PRst and to provide free medical insurance countrywide. Indeed many families can ill afford the travel and cost of care for a child with JIA.

  1. McErlane F et al. Rheumatology (Oxford). 2016 Jul


Table 1 ACR


Table 2 ACR


Table 3 ACR


Disclosure: C. Freychet, None; M. Agarwal, None; S. Mittal, None; A. Shivpuri, None; A. Singh, None; V. Dinand, None; S. Sawhney, None.

To cite this abstract in AMA style:

Freychet C, Agarwal M, Mittal S, Shivpuri A, Singh A, Dinand V, Sawhney S. Factors Impacting Referral of Juvenile Idiopathic Arthritis Patients to a Tertiary Level Pediatric Rheumatology Center in North India [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/factors-impacting-referral-of-juvenile-idiopathic-arthritis-patients-to-a-tertiary-level-pediatric-rheumatology-center-in-north-india/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/factors-impacting-referral-of-juvenile-idiopathic-arthritis-patients-to-a-tertiary-level-pediatric-rheumatology-center-in-north-india/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology